Literature DB >> 7306216

Contamination of albumin by alpha 1-acid glycoprotein.

J J Lima, L B Salzer.   

Abstract

Mesh:

Substances:

Year:  1981        PMID: 7306216     DOI: 10.1016/0006-2952(81)90596-7

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  8 in total

1.  Binding of prazosin and propranolol at variable alpha 1-acid glycoprotein and albumin concentrations.

Authors:  G Sager; R Jaeger; C Little
Journal:  Br J Clin Pharmacol       Date:  1989-02       Impact factor: 4.335

2.  Interaction of mixed micelles formed from glycocholic acid and lecithin with the protein binding of various drugs.

Authors:  T W Guentert; S Oie; L Paalzow; B M Frey; R Brandt; L J Aarons; M Rowland
Journal:  Br J Clin Pharmacol       Date:  1987-05       Impact factor: 4.335

3.  The binding of ketamine to plasma proteins: emphasis on human plasma.

Authors:  P G Dayton; R L Stiller; D R Cook; J M Perel
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

4.  The influence of blood collection technique on serum and plasma protein binding of disopyramide.

Authors:  D B Haughey; J J Lima
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

5.  Drug binding in sera deficient in lipoproteins, albumin or orosomucoid.

Authors:  E Pike; P Kierulf; B Skuterud; J E Bredesen; P K Lunde
Journal:  Br J Clin Pharmacol       Date:  1983-09       Impact factor: 4.335

6.  Disopyramide pharmacokinetics and bioavailability following the simultaneous administration of disopyramide and 14C-disopyramide.

Authors:  J J Lima; D B Haughey; C V Leier
Journal:  J Pharmacokinet Biopharm       Date:  1984-06

7.  Relationship between alpha 1-acid glycoprotein and plasma binding of disopyramide and mono-N-dealkyldisopyramide.

Authors:  J E Bredesen; P Kierulf
Journal:  Br J Clin Pharmacol       Date:  1984-11       Impact factor: 4.335

8.  Prolonged variability in plasma protein binding of disopyramide after acute myocardial infarction.

Authors:  B M David; K F Ilett; E G Whitford; N S Stenhouse
Journal:  Br J Clin Pharmacol       Date:  1983-04       Impact factor: 4.335

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.